Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 11, 1998

View Archived Issues

Connetics: Q4 and FY 1997 highlights

Life Medical Sciences updates shareholders

Inhale Therapeutic Systems: Q4 and FY 1997 highlights

New agents for IBS from Nippon Shinyaku

Novel mitomycin C derivative reported by Sagami

Potent and safe new quinolones from Daiichi

New implant for delivery of LHRH agonists

Novel compound MK6059 isolated by Meiji Seika/Mitsubishi Chemical

Wyeth-Ayerst describes synthesis and pharmacological profile of new agent for stroke

PLA2 inhibitors --BM-16.2115, mepacrine and manoalide-- reduce human leukocyte chemotaxis

Institute of Microbial Chemistry discovers new antibacterial/cytotoxic antibiotic

SGLT inhibitors under evaluation at Tanabe as antidiabetic agents

Antibradycardic M2 receptor antagonists prepared at Yamanouchi

Warning issued for Duract related to potential hepatotoxicity

Safety warnings issued by FDA for Hismanal

Idec evaluates humanized anti-gp39 antibody in phase I

GeneMedicine and Corange progress in cancer alliance

Lilly describes second-generation NK1 antagonist

New antiinflammatory agents prepared by Brazilian academics

Vorozole safe and effective in phase II EORTC study

Preclinical profile of S-4661, a new carbapenem, characterized

Macritonin clinical trial update

Topoisomerase I inhibitor tested in phase I trial

Two combinations compared for treatment of multidrug-resistant falciparum malaria

Targeted Genetics to report tgDCC-E1A clinical data

Anti-Candida activity of voriconazole compared to other antifungal agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.